RESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: The Shenlian formula (SL) is a Chinese medicine formula used to curb the development of atherosclerosis (AS) and cardiovascular disease in clinical practice. However, owing to the complexity of compounds and their related multiple targets in traditional Chinese medicine (TCM), it remains difficult and urgent to elucidate the underlying mechanisms at a holistic level. AIM: To investigate the intrinsic mechanisms by which SL suppresses AS progression and to gain new insight into its clinical use. METHODS: We proposed a network pharmacology-based workflow to evaluate the mechanism by which SL affects AS via data analysis, target prediction, PPI network construction, GO and KEGG analyses, and a "drug-core ingredient-potential target-key pathway" network. Then, non-targeted lipidomic analysis was performed to explore the differential lipid metabolites in AS rats, revealing the possible mechanism by which SL affects atherosclerotic progression. Moreover, an AS rabbit model was constructed and gavaged for SL intervention. Serum lipid profiles and inflammatory cytokine indices were tested as an indication of the mitigating effect of SL on AS. RESULTS: A total of 89 bioactive compounds and 298 targets related to SL and AS, which play essential roles in this process, were identified, and a component-target-disease network was constructed. GO and KEGG analyses revealed that SL regulated metabolic pathway, lipids and atherosclerosis, the PI3K-Akt pathway, the MAPK pathway and so on. In vivo experimental validation revealed that a total of 43 different lipid metabolites regulated by SL were identified by non-targeted lipidomics, and glycerophospholipid metabolism was found to be an important mechanism for SL to interfere with AS. SL reduced the plaque area and decreased the levels of inflammatory cytokines (TNF-α and IL-4) and blood lipids (TC, TG, LDL-C, and ApoB) in HFD-induced AS models. In addition, HDL and ApoA1 levels are increased. PLA2 and Lipin1 are highly expressed in AS model, indicating their role in destabilizing glycerophosphatidylcholine metabolism and contributing to the onset and progression of ankylosing spondylitis. Moreover, SL intervention significantly reduced the level of pro-inflammatory cytokines; significantly down-regulated NF-kB/p65 expression, exhibiting anti-inflammatory activity. CONCLUSION: The Shenlian formula (SL) plays a pivotal role in the suppression of AS progression by targeting multiple pathways and mechanisms. This study provides novel insights into the essential genes and pathways associated with the prognosis and pathogenesis of AS.
Assuntos
Aterosclerose , Medicamentos de Ervas Chinesas , Farmacologia em Rede , Animais , Medicamentos de Ervas Chinesas/farmacologia , Aterosclerose/tratamento farmacológico , Aterosclerose/metabolismo , Aterosclerose/patologia , Ratos , Masculino , Coelhos , Ratos Sprague-Dawley , Progressão da Doença , Modelos Animais de Doenças , Lipídeos/sangue , Metabolismo dos Lipídeos/efeitos dos fármacos , Citocinas/metabolismoRESUMO
Spatiotemporal correlation function is the basic characteristic of dynamic laser speckle and the basis of various applications. The correlation function of the speckle intensity from a 3D target in turbulent atmosphere is derived based on the model of random phase screen and Fresnel Kirchhoff Diffraction Formula, and a fast algorithm based on FFT is developed. The particularity of dynamic speckle in turbulence is numerically analyzed and discussed. The results show that the speckle intensity fluctuates at two independent scales both in space and time domain, which are affected by target size and atmospheric turbulence respectively. In particular, the time scale caused by turbulence is also affected by the target translating velocity and the wind direction. The theory and algorithm developed in this paper can play important roles in applications of laser speckle such as remote detection in atmospheric environment.